Spire Healthcare Group PLC (SPI) Given Consensus Recommendation of “Hold” by Analysts

Share on StockTwits

Spire Healthcare Group PLC (LON:SPI) has earned a consensus recommendation of “Hold” from the eight research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and one has given a buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is GBX 192.20 ($2.51).

Several equities research analysts recently commented on the company. Berenberg Bank reiterated a “sell” rating and set a GBX 120 ($1.57) target price on shares of Spire Healthcare Group in a report on Tuesday, September 18th. Peel Hunt reiterated an “under review” rating on shares of Spire Healthcare Group in a report on Tuesday, September 18th. Liberum Capital reiterated a “hold” rating and set a GBX 176 ($2.30) target price on shares of Spire Healthcare Group in a report on Tuesday, September 25th. Barclays downgraded Spire Healthcare Group to an “underweight” rating and dropped their price objective for the stock from GBX 190 ($2.48) to GBX 130 ($1.70) in a report on Friday, September 28th. Finally, JPMorgan Chase & Co. restated a “neutral” rating on shares of Spire Healthcare Group in a report on Wednesday, January 2nd.

In other news, insider Simon Rowlands bought 200,000 shares of the firm’s stock in a transaction dated Monday, November 5th. The stock was bought at an average price of GBX 132 ($1.72) per share, for a total transaction of £264,000 ($344,962.76).

Shares of LON:SPI traded up GBX 2.60 ($0.03) during mid-day trading on Friday, hitting GBX 118.80 ($1.55). 875,025 shares of the company traded hands, compared to its average volume of 1,770,000. Spire Healthcare Group has a 52-week low of GBX 206.40 ($2.70) and a 52-week high of GBX 362.10 ($4.73).

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Read More: How is inflation measured?

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: Analysts Expect Select Medical Holdings Co.  Will Announce Quarterly Sales of $1.28 Billion
Zacks: Analysts Expect Select Medical Holdings Co. Will Announce Quarterly Sales of $1.28 Billion
Zacks: Brokerages Anticipate Syros Pharmaceuticals Inc  Will Post Earnings of -$0.50 Per Share
Zacks: Brokerages Anticipate Syros Pharmaceuticals Inc Will Post Earnings of -$0.50 Per Share
Safe Trade Coin Market Capitalization Tops $23,428.00
Safe Trade Coin Market Capitalization Tops $23,428.00
Storm  One Day Volume Hits $2.09 Million
Storm One Day Volume Hits $2.09 Million
Brokerages Set Bellatrix Exploration Ltd  PT at $0.38
Brokerages Set Bellatrix Exploration Ltd PT at $0.38
Lamar Advertising Co  Given Average Rating of “Hold” by Analysts
Lamar Advertising Co Given Average Rating of “Hold” by Analysts


Leave a Reply

© 2006-2019 Ticker Report